We came across a bullish thesis on Eli Lilly and Company on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on LLY. Eli Lilly and Company's share was trading at $798.89 as of July 23rd. LLY’s trailing and forward P/E were 65.00 and 36.63 respectively according to Yahoo Finance.
Eli Lilly remains a compelling investment opportunity, underpinned by strong financial performance, leadership in the fast-growing GLP-1 market, and a transformative oral GLP-1 pipeline. Despite a ~10% drop in share price following its earnings report, Lilly...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.